Inventor
BURAKOV DARYA
US29 patents
⚠️ This page may combine multiple inventors who share the name “BURAKOV DARYA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
28 patentsUS9816110B2Nov 14, 2017
CHO integration sites and uses thereof
REGENERON PHARMA19 citations92
US9228012B2Jan 5, 2016
Production cell line enhancers
REGENERON PHARMA6 citations84
US9206455B2Dec 8, 2015
Fucosylation-deficient cells
REGENERON PHARMA4 citations84
US9193786B2Nov 24, 2015
Production cell line enhancers
REGENERON PHARMA6 citations84
US9079954B2Jul 14, 2015
Production cell line enhancers
REGENERON PHARMA6 citations84
US11530277B2Dec 20, 2022
Compositions and methods for making antibodies based on use of an expression-enhancing locus
REGENERON PHARMA2 citations73
US11268109B2Mar 8, 2022
CHO integration sites and uses thereof
REGENERON PHARMA1 citations73
US10227401B2Mar 12, 2019
Production cell line enhancers
REGENERON PHARMA2 citations73
US9688751B2Jun 27, 2017
Production cell line enhancers
REGENERON PHARMA2 citations73
US9550823B2Jan 24, 2017
Fucosylation-deficient cells
REGENERON PHARMA2 citations73
US11085053B2Aug 10, 2021
Efficient selectivity of recombinant proteins
REGENERON PHARMA1 citations71
US10457959B2Oct 29, 2019
Efficient selectivity of recombinant proteins
REGENERON PHARMA2 citations71
US9758592B2Sep 12, 2017
Recombinant cell surface capture proteins
REGENERON PHARMA3 citations71
US9732357B2Aug 15, 2017
Efficient selectivity of recombinant proteins
REGENERON PHARMA3 citations71
US10006070B2Jun 26, 2018
Fucosylation-deficient cells
REGENERON PHARMA1 citations63
US12565667B2Mar 3, 2026
CHO integration sites and uses thereof
REGENERON PHARMA0 citations62
US12528883B2Jan 20, 2026
Compositions and methods for making antibodies based on use of expression-enhancing loci
REGENERON PHARMA0 citations62
US12503520B2Dec 23, 2025
Compositions and methods for making antibodies based on use of an expression-enhancing locus
REGENERON PHARMA0 citations62
US12054751B2Aug 6, 2024
Fucosylation-deficient cells
REGENERON PHARMA0 citations62
US11788102B2Oct 17, 2023
CHO integration sites and uses thereof
REGENERON PHARMA0 citations62
US11560550B2Jan 24, 2023
Fucosylation-deficient cells
REGENERON PHARMA0 citations62
US11512144B2Nov 29, 2022
Compositions and methods for making antibodies based on use of an expression-enhancing loci
REGENERON PHARMA0 citations62
USRE48651EJul 20, 2021
Production cell line enhancers
REGENERON PHARMA0 citations62
US9382315B2Jul 5, 2016
Production cell line enhancers
REGENERON PHARMA2 citations62
US12577326B2Mar 17, 2026
Recombinant cell surface capture proteins
REGENERON PHARMA0 citations60
US12234472B2Feb 25, 2025
Eukaryotic cells comprising adenovirus-associated virus polynucleotides
REGENERON PHARMA0 citations59
US10611831B2Apr 7, 2020
Production cell line enhancers
REGENERON PHARMA0 citations52
US10351622B2Jul 16, 2019
Production cell line enhancers
REGENERON PHARMA0 citations52